Stay updated on Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial

Sign up to get notified when there's something new on the Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.1%
    Check dated 2025-06-13T16:16:25.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-06T10:03:22.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-30T04:52:31.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.3%
    Check dated 2025-05-23T02:11:20.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-05-01T06:19:30.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page has undergone significant content removal, particularly regarding a clinical trial for recurrent/metastatic head and neck squamous cell carcinoma (HNSCC), including detailed descriptions of the trial's purpose, inclusion and exclusion criteria, and the previous version number. The new version introduces a new revision number but lacks the critical information about the trial.
    Difference
    17%
    Check dated 2025-04-16T20:34:05.000Z thumbnail image

Stay in the know with updates to Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial page.